$HIPH -PR/News out! #CBD beverage full launch of LALPINA

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
82
$HIPH -PR/News out! #CBD beverage full launch of LALPINA HYDRO CBD announced for August 27


American Premium Water Corp. (OTC:HIPH) Announces CBD Beverage Full Launch
GlobeNewswire•July 25, 2018

PLAYA VISTA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that the Company will begin selling its LALPINA Hydro CBD product on August 27th on its website and select retail channels. The Company has been able to procure a domestic manufacturer who can provide the supply to meet the growing demand of LALPINA Hydro CBD.

Ryan Fishoff, CEO American Premium Water Corporation commented: “Happy to finally announce a delivery date for LALPINA Hydro CBD. There has been tremendous pre order interest & demand for this product. I am excited to begin marketing, promoting and selling our transformative product. The CBD market is growing everyday as more and more consumers are learning how powerful CBD can be as an all-natural alternative to opioids, and can be a natural remedy for such ailments as asthma, insomnia, anxiety, depression, arthritis, among others. I wish we could have delivered the product on schedule, but there were several opportunities such as (FashionCoinX, THRD Coin, Worthy) that we had to take advantage of that were factors in the delay. I hate not delivering on time, but in the big picture, this will not blunt shareholder value.”

Since June, The Company has made two acquisitions, the Worthy (www.worthylux.com street wear license, and the operating agreement for the crypto currency, blockchain platform FashionCoinX (www.fashioncoinx.com) exchange. In addition, the Company recently announced the creation of the multi-brand THRD Coinutility token. These additions to the Company’s portfolio fit within the “Brand.Luxury.Lifestyle” strategy it released earlier in the year. In addition to executing these transactions, ramping up the mass production of LALPINA Hydro CBD attributed to some of the delays as well.

“With a new product like LALPINA Hydro CBD, there were some teething issues in the ramp up to production. This product is a market frontrunner right out the gate considering the lack of a comparable product currently on sale. Unlike the other CBD waters that are currently at retail, the molecular structure of LALPINA Hydro CBD allows for greater bio availability which leads to a greater & quicker absorption rate compared to regular CBD oil or CBD water. The Company will need to use less CBD to create a greater benefit, which will allow for a higher gross margin per unit,” added Mr. Fishoff.

The Company first announced at the end of January before the Super Bowl that it had developed a prototype of LALPINA CBD Hydro beverage. Delivering the CBD prototype, along with significant debt reduction, and increased revenues were some of the first milestones the Company reached under the direction of Mr. Fishoff. Developing LALPINA Hydro CBD was one of the Company’s primary initiatives for the 2018 fiscal year. CBD, the natural phycannbinoid extracted from cannabis, has shown in studies to have many therapeutic and medical benefits. The CBD market, which generated $820 million of sales in 2017, is projected to grow at 54% CAGR to $3 billion in 2020 according to GreenWave Advisors.

“The CBD market continues to grow at a blistering pace. Now that we will be able to capitalize on it and cultivate our distribution channels, we being to look to other areas in the space that have large growth potential. Incorporating THC into the formula and exploring pet CBD beverages are two areas the Company will be looking to expand into over the next 3-9 months. The LALPINA brand has over 1m followers on Instagram. It is time to start monetizing them. Just like the other acquisitions that the Company consummated over the past few months, the goal for LALPINA is to become a full-fledged lifestyle luxury brand that will offer multiple variations of water, energy, CBD, and THC infused beverages (and for those consumers pets as well). As we roll out LALPINA Hydro CBD, I look forward on updating the investor community with the Company’s progress in the CBD space and other high growth sectors.” Mr. Fishoff concluded.

American Premium Water Corp. is the publicly holding trading company that owns LALPINA HYDRO, LALPINA HYDRO CBD, Gents, Worthy, and FashionCoinX.

Please follow us on our social media outlets listed below:

@americanpremium

@lalpinabrands

@GentsCo

@FashionCoinX

#Gentsco

#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s, Nordstrom, and Saks Fifth Avenue.

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 92

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 88

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Mynd.ai Alters ADS Ratio Affecting Share Dynamics

Updated Category News Views 82

Analyzing Mynd.ai's ADS Ratio Tweak When Mynd.ai decides to shake things up with the American Depositary Shares (ADS) ratio, it's like they're throwing a curveball straight at Wall Street. Listen up, this isn't just a deck shuffle—it's a fundamental tweak that could play a big role in the stock’s perceived value. Starting December 7, 2027, one ADS will leap from...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 80

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 100

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 204

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Nemazee Fellowship Advances Clemency and Justice Reform

Updated Category News Views 96

Nemazee Fellowship: A Catalyst for Change You're probably wondering what's really happening when a couple like Hassan and Nazie Nemazee put their name on a legal fellowship. Skipping the melodrama, it's all about making a dent in the criminal justice system. These two aren't just slapping their name on a plaque—they're throwing real support behind actions that matter....

Continue Reading
Havertys Dividend: A Steady Payout Tradition Continues

Updated Category News Views 163

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

Continue Reading
IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Updated Category News Views 63

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Continue Reading

Top 5 Most Recently Viewed Articles

Apertura Gene Therapy Collaborates on Prion Disease Treatment

Updated Category News Views 123

Apertura Gene Therapy Teams Up with Broad Institute Apertura Gene Therapy, a leading biotechnology firm committed to pioneering solutions in gene therapy, is collaborating with the Broad Institute, which is renowned for its groundbreaking research initiatives. The project aims to advance the development of a novel gene therapy targeting prion disease using an engineered...

Continue Reading
Bausch & Lomb Exceeds Expectations with Strong Q3 Growth

Updated Category News Views 67

Bausch & Lomb Achieves Impressive Third Quarter Results Bausch & Lomb Corp. (NYSE:BLCO) has recently captured attention in the financial markets after delivering strong third-quarter results for 2024. H.C. Wainwright, a prominent investment firm, revised the stock price target upward to $23.00 from the previous $22.00 while maintaining a Buy rating on the stock. This...

Continue Reading
Experience Winter Delights with BIGGBY® COFFEE's TWIX® Treats

Updated Category News Views 141

Discover the Seasonal Magic of BIGGBY® COFFEE The new limited-time winter offerings from BIGGBY® COFFEE are designed to delight cocoa and coffee lovers alike. This season, fans can indulge in a unique Salted Caramel lineup inspired by TWIX® candy. These festive beverages are available from early January through late February, providing a decadent way to enjoy the...

Continue Reading
Borr Drilling Limited's New Offering: What Investors Should Know

Updated Category News Views 229

Borr Drilling Limited Plans Significant Share Offering Borr Drilling Limited (NYSE: BORR) has recently announced plans to conduct a public offering of its common shares, intending to raise approximately $85 million in gross proceeds. The company aims to offer around 21 million shares in this equity initiative, reflecting its commitment to continued growth and investment...

Continue Reading